Redesigning Berberines and Sanguinarines to Target Soluble Epoxide Hydrolase for Enhanced Anti-Inflammatory Efficacy
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c02202 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Xing-Zhou Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medicinal Molecule Science and Pharmaceutical Engineering, School of Chemistry and Chemical Engineering, Beijing Institute of Techn…. Hauptthemen laut MEDLINE: Epoxide Hydrolases, Berberine, Isoquinolines, Benzophenanthridines. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Amino-berberine has remained underexplored due to limited biological evaluation and total synthesis approaches. In inflammation therapy, soluble Epoxide Hydrolase (sEH) is a promising target, yet natural scaffolds remain underutilized. Our study advances the field by redesigning natural compounds─berberine and sanguinarine─with strategic urea modifications and hydrogenated frameworks, creating novel sEH inhibitors with enhanced in vivo efficacy. Through total synthesis and structure-activity relationship studies of amino-berberine derivatives, chiral tetrahydroberberine (R)-14i (coded LXZ-42) emerged as the most potent lead, with an IC50 value of 1.20 nM. (R)-14i showed reduced CYP enzyme impact, potent therapeutic effects on acute pancreatitis, no acute in vivo toxicity, and superior pharmacokinetic properties, with an oral bioavailability of 89.3%. Structural insights from crystallography of (R)-14i bound to sEH revealed key interactions: three with the tetrahydroberberine framework and three hydrogen bonds with the urea group, highlighting (R)-14i as a novel lead for sEH-targeted therapies in inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Medicinal Molecule Science and Pharmaceutical Engineering, School of Chemistry and Chemical Engineering, Beijing Institute of Technology, Beijing 102488, China.
- College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
- Research Center for Brain Health, PazhouLab, Guangzhou 510330, China.
Förderung
- Ministry of Science and Technology of the People's Republic of China
- National Natural Science Foundation of China
Zitieren
APA
Liu, X. Z., Du, X. Y., Xie, W. S., Ding, J., Zhu, M. Z., Feng, Z. Q., Wang, H., Feng, Y., Yu, M. J., Liu, S. M., Liu, W. T., Zhu, X. H., & Liang, J. H. (2024). Redesigning Berberines and Sanguinarines to Target Soluble Epoxide Hydrolase for Enhanced Anti-Inflammatory Efficacy. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c02202
Vancouver
Liu XZ, Du XY, Xie WS, Ding J, Zhu MZ, Feng ZQ, et al. Redesigning Berberines and Sanguinarines to Target Soluble Epoxide Hydrolase for Enhanced Anti-Inflammatory Efficacy. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c02202
BibTeX
@article{Liu2024,
author = {Liu, Xing-Zhou and Du, Xiao-Yu and Xie, Wei-Song and Ding, Jing and Zhu, Min-Zhen and Feng, Zi-Qiang and Wang, Hao and Feng, Yue and Yu, Ming-Jia and Liu, Si-Meng and Liu, Wen-Tian and Zhu, Xin-Hong and Liang, Jian-Hua},
title = {Redesigning Berberines and Sanguinarines to Target Soluble Epoxide Hydrolase for Enhanced Anti-Inflammatory Efficacy},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c02202}
}
EUVIMED